Sari E Jalkanen
Overview
Explore the profile of Sari E Jalkanen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
397
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jalkanen S, Lahesmaa-Korpinen A, Heckman C, Rantanen V, Porkka K, Hautaniemi S, et al.
Exp Hematol
. 2012 Jun;
40(9):705-714.e3.
PMID: 22659387
Tyrosine kinase inhibitors (TKIs) have dramatically improved treatment outcomes in chronic myeloid leukemia (CML), but a proportion of patients fail to achieve optimal molecular response. By using a phosphoproteomic approach,...
2.
Koskela H, Eldfors S, Ellonen P, van Adrichem A, Kuusanmaki H, Andersson E, et al.
N Engl J Med
. 2012 May;
366(20):1905-13.
PMID: 22591296
Background: T-cell large granular lymphocytic leukemia is a rare lymphoproliferative disorder characterized by the expansion of clonal CD3+CD8+ cytotoxic T lymphocytes (CTLs) and often associated with autoimmune disorders and immune-mediated...
3.
Jalkanen S, Vakkila J, Kreutzman A, Nieminen J, Porkka K, Mustjoki S
Exp Hematol
. 2010 Sep;
39(1):102-113.e1.
PMID: 20869423
Objective: In chronic myeloid leukemia (CML), uncontrolled tyrosine kinase activity of the BCR-ABL1 oncoprotein results in aberrant signaling pathways and increased cell proliferation. Acquired immune tolerance to leukemic antigens further...